// App-Quantinova.ai

4010 : Identification of novel targeted and immunotherapy combinations by a high throughput assay of T cell-mediated cytotoxicity

Researchers

Presenter

  • Leila Williams

Principal Investigators

  • Shruti Malu

  • Jodi McKenzie

  • Rina Mbofung

  • Marie-Andree Forget

  • Chantale Bernatchez

  • Patrick Hwu

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • Dana-Farber Cancer Institute, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Skin carcinoma

  • Melanoma

  • Solid malignancies

Biomarkers

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved